Multimodal KCNQ1 Variant-Effect Maps Define Ion Channel Mechanisms and Disease Risk
In brief
KCNQ1 mapping finds strong pathogenic evidence for 1,757 variants
Functional testing of 13,403 KCNQ1 variants found strong evidence of pathogenicity for 1,757 and moderate evidence of benignity for 6,660. Most pathogenic variants acted through dominant-negative effects and were linked to higher arrhythmia risk than variants causing loss of one gene copy; the atlas adds evidence for interpreting uncertain variants, but does not by itself settle every patient's risk.
- Journal
- Circulation (Q1)
- Published
- 20 October 2026
- Study design
- Case-control study
- Evidence level
- Level 3, Low (CEBM 3b)
- Authors
- M Lorena Harvey, Ellen Osborn, Megan C Lancaster, Jeremy E Smith, Qianyi Shen, Temidayo A Abe, et al.
- PMID
- 42899351
- DOI
- 10.1161/CIRCULATIONAHA.126.080900
Why clinicians should know about it
- Picked for Genetics (clinical) (top studies of the week, 25 October 2026): Functional KCNQ1 atlas directly supports VUS classification and risk
Abstract
BACKGROUND: Variants in the ion channel gene KCNQ1 are the leading cause of congenital long QT syndrome (LQTS), a disorder characterized by QT prolongation and risk of fatal arrhythmias. The expanding use of genetic testing has led to the identification of numerous variants of uncertain significance, complicating clinical interpretation and risk stratification. Functional characterization of KCNQ1 variants is essential to define their role in long QT syndrome and advance precision medicine in cardiovascular care. METHODS: We generated a nearly comprehensive variant library of 13 403 protein-coding variants in KCNQ1. Using 4 pooled assays followed by high-throughput sequencing, we characterized the variants' effects on cell surface abundance and channel function in both the variant-only and heterozygous states. Case-control analyses and data from large-scale biobanks were used to assess the clinical impact of loss-of-function variants on QT prolongation and long QT syndrome. Heterozygous assay results were used to determine dominant-negative effects, which were also evaluated for association with arrhythmia risk. Protein structural clustering of distinct classes of deleterious variants was analyzed. RESULTS: Across the 4 assays, we generated 49 305 functional measurements of KCNQ1 variants. Of the 13 403 KCNQ1 studied variants, 1757 demonstrated strong pathogenic evidence, and 6660 showed moderate benign evidence. Loss-of-function variants were significantly associated with QT prolongation and long QT syndrome in case-control and biobank analyses. Deleterious variants clustered within distinct structural domains based on their functional classification. A majority of pathogenic variants exhibited dominant-negative effects; these variants were linked to a higher risk of arrhythmia diagnoses than were haploinsufficient variants. CONCLUSIONS: This comprehensive KCNQ1 functional atlas provides novel functional evidence for most KCNQ1 variants of uncertain significance. It also reveals mechanistic principles linking genetic variation to ion channel biology and arrhythmia susceptibility, advancing cardiovascular precision medicine.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.